1,154
Participants
Start Date
February 28, 2010
Primary Completion Date
October 31, 2013
Study Completion Date
January 31, 2016
Investigator´s choice of chemotherapy
BIBW 2992 in a medium dose in combination with Paclitaxel to explore safety and efficacy versus investigator´s choice of chemotherapy
BIBW 2992
BIBW 2992 will be given in a medium dose in combination with Paclitaxel to explore safety and efficacy versus investigator´s choice of chemotherapy
Boehringer Ingelheim Investigational Site, Buenos Aires
Boehringer Ingelheim Investigational Site, Kingswood
Boehringer Ingelheim Investigational Site, South Brisbane
Boehringer Ingelheim Investigational Site, Box Hill
Boehringer Ingelheim Investigational Site, Fitzroy
Boehringer Ingelheim Investigational Site, Wodonga
Boehringer Ingelheim Investigational Site, Salzburg
Boehringer Ingelheim Investigational Site, Aalst
Boehringer Ingelheim Investigational Site, Brussels
Boehringer Ingelheim Investigational Site, Duffel
Boehringer Ingelheim Investigational Site, La Louvière
Boehringer Ingelheim Investigational Site, Liège
Boehringer Ingelheim Investigational Site, Middelheim
Boehringer Ingelheim Investigational Site, Ottignies
Boehringer Ingelheim Investigational Site, Porto Alegre
Boehringer Ingelheim Investigational Site, Beijing
Boehringer Ingelheim Investigational Site, Changchun
Boehringer Ingelheim Investigational Site, Chengdu
Boehringer Ingelheim Investigational Site, Fuzhou
Boehringer Ingelheim Investigational Site, Guangzhou
Boehringer Ingelheim Investigational Site, Hangzhou
Boehringer Ingelheim Investigational Site, Nanjing
Boehringer Ingelheim Investigational Site, Shanghai
Boehringer Ingelheim Investigational Site, Helsinki
Boehringer Ingelheim Investigational Site, Bayonne
Boehringer Ingelheim Investigational Site, Caen
Boehringer Ingelheim Investigational Site, Dijon
Boehringer Ingelheim Investigational Site, La Tronche
Boehringer Ingelheim Investigational Site, Lyon
Boehringer Ingelheim Investigational Site, Paris
Boehringer Ingelheim Investigational Site, Saint-Herblain
Boehringer Ingelheim Investigational Site, Villejuif
Boehringer Ingelheim Investigational Site, Berlin
Boehringer Ingelheim Investigational Site, Essen
Boehringer Ingelheim Investigational Site, Esslingen am Neckar
Boehringer Ingelheim Investigational Site, Gauting
Boehringer Ingelheim Investigational Site, Hamburg
Boehringer Ingelheim Investigational Site, Hanover
Boehringer Ingelheim Investigational Site, Heidelberg
Boehringer Ingelheim Investigational Site, Mainz
Boehringer Ingelheim Investigational Site, Münster
Boehringer Ingelheim Investigational Site, Budapest
Boehringer Ingelheim Investigational Site, Pécs
Boehringer Ingelheim Investigational Site, Törökbálint
Boehringer Ingelheim Investigational Site, Chennai
Boehringer Ingelheim Investigational Site, Jaipur
Boehringer Ingelheim Investigational Site, Maharashtra
Boehringer Ingelheim Investigational Site, Mumbai
Boehringer Ingelheim Investigational Site, Nashik, Maharashtra
Boehringer Ingelheim Investigational Site, Kfar Saba
Boehringer Ingelheim Investigational Site, Petah Tikva
Boehringer Ingelheim Investigational Site, Tel Litwinsky
Boehringer Ingelheim Investigational Site, Avellino
Boehringer Ingelheim Investigational Site, Aviano (PN)
Boehringer Ingelheim Investigational Site, Bergamo
Boehringer Ingelheim Investigational Site, Genova
Boehringer Ingelheim Investigational Site, Milan
Boehringer Ingelheim Investigational Site, Monza (mi)
Boehringer Ingelheim Investigational Site, Ravenna
Boehringer Ingelheim Investigational Site, Roma
Boehringer Ingelheim Investigational Site, Distrito Federal
Boehringer Ingelheim Investigational Site, Maastricht
Boehringer Ingelheim Investigational Site, Nieuwegein
Boehringer Ingelheim Investigational Site, Arequipa
Boehringer Ingelheim Investigational Site, La Victoria
Boehringer Ingelheim Investigational Site, Gdansk
Boehringer Ingelheim Investigational Site, Olsztyn
Boehringer Ingelheim Investigational Site, Otwock
Boehringer Ingelheim Investigational Site, Warsaw
Boehringer Ingelheim Investigational Site, Obninsk
Boehringer Ingelheim Investigational Site, Saint Petersburg
Boehringer Ingelheim Investigational Site, Goyang
Boehringer Ingelheim Investigational Site, Hwasun
Boehringer Ingelheim Investigational Site, Seoul
Boehringer Ingelheim Investigational Site, A Coruña
Boehringer Ingelheim Investigational Site, Barcelona
Boehringer Ingelheim Investigational Site, Madrid
Boehringer Ingelheim Investigational Site, Mataró
Boehringer Ingelheim Investigational Site, Málaga
Boehringer Ingelheim Investigational Site, Valencia
Boehringer Ingelheim Investigational Site, Kaohsiung City
Boehringer Ingelheim Investigational Site, Taichung
Boehringer Ingelheim Investigational Site, Tainan City
Boehringer Ingelheim Investigational Site, Taipei
Boehringer Ingelheim Investigational Site, Taoyuan District
Boehringer Ingelheim Investigational Site, Dnipropetrovks
Boehringer Ingelheim Investigational Site, Donetsk
Boehringer Ingelheim Investigational Site, Kharkiv
Boehringer Ingelheim Investigational Site, Kyiv
Boehringer Ingelheim Investigational Site, Brighton
Boehringer Ingelheim Investigational Site, Dundee
Boehringer Ingelheim Investigational Site, Exeter
Boehringer Ingelheim Investigational Site, London
Boehringer Ingelheim Investigational Site, Maidstone
Boehringer Ingelheim Investigational Site, Manchester
Boehringer Ingelheim Investigational Site, Sutton, Surrey
Boehringer Ingelheim Investigational Site, Truro, Cornwall
Lead Sponsor
Boehringer Ingelheim
INDUSTRY